sb 216763 has been researched along with Hypoxia-Ischemia, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, R; Hu, X; Lenahan, C; Li, B; Li, S; Liu, J; Qu, H; Si, W; Tian, T; Wang, L; Wang, Q; Zuo, G | 1 |
| D'Angelo, B; Ek, CJ; Mallard, C; Sandberg, M; Sun, Y; Zhu, C | 1 |
2 other study(ies) available for sb 216763 and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
AT1R/GSK-3
Topics: Angiotensin II; Animals; Apoptosis; Blood Glucose; Cerebral Infarction; Flow Cytometry; Glycogen Synthase Kinase 3 beta; Hypoxia-Ischemia, Brain; In Vitro Techniques; Indoles; Maleimides; Neurons; Oxygen; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrazolium Salts; TOR Serine-Threonine Kinases; Valsartan | 2020 |
GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling.
Topics: Animals; Animals, Newborn; Brain; Brain Infarction; Caspase 3; Cerebrovascular Circulation; Disease Models, Animal; Doublecortin Domain Proteins; Drug Administration Schedule; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Hypoxia-Ischemia, Brain; Indoles; Maleimides; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Nerve Tissue Proteins; Neuropeptides; STAT3 Transcription Factor; Stem Cells; Subcellular Fractions | 2016 |